[EN] (HETERO)ARYLAMINO-CYCLOHEXYL-SULFONYL DERIVATIVES AS CCR6 INHIBITORS<br/>[FR] DÉRIVÉS D'(HÉTÉRO)ARYLAMINO-CYCLOHEXYL-SULFONYLE UTILES EN TANT QU'INHIBITEURS DE CCR6
申请人:QILU REGOR THERAPEUTICS INC
公开号:WO2022173849A1
公开(公告)日:2022-08-18
The present disclosure provides a compound of Formula (I) a pharmaceutically acceptable salt, or a stereoisomer and their use in, e.g. treating a condition, disease or disorder modulated at least in part by CCR6. This disclosure also features compositions containing the same as well as methods of using and making the same.